Bacteriocin F Activity Against Drug-Resistant Helicobacter pylori

Daoyan Wu published data on April 27, 2026, investigating a novel Bacteriocin F derived from Lactobacillus casei T1. The dataset likely contains results from mouse models showing the bacteriocin's effects on bacterial growth, biofilm disruption, virulence gene expression, and gut microbiota composition.

Use Cases

• Analyze antimicrobial efficacy based on bacterial growth inhibition data mentioned in the description
• Study biofilm disruption mechanisms based on biofilm formation data
• Model gut microbiota remodeling based on changes in beneficial and resistance-related taxa
• Evaluate drug delivery systems based on nanocomposite hydrogel gastric stability and release data

Strengths

• Data is openly licensed under CC-BY-4.0
• The dataset includes results from mouse models, providing in vivo validation

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download

Provenance

Source

Daoyan Wu

Freshness

Last updated 2026-04-27 09:01:52